What’s New in Hip Replacement

Abstract

The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party-that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer.

Zurich Cementless Dual Mobility Cup for Canine Total Hip Prosthesis: Implant Characteristics and Surgical Outcome in 105 Cases

“…A potential disadvantage for some, but not all, DM cups used in humans is that they lack screw holes. 28 30 31 32 As with all monolithic cups, the inability to visualize the floor of the acetabulum during the impaction process and not being able to anchor the outer shell with screws may compromise overall fixation of the DM cup. This is less likely to be a cause of failure in primary THA procedures than with revision procedures, where there may be significant bone loss associated with the acetabulum.…”

“…The cementless hip prosthesis is now widely used in both the human and veterinary fields, especially in young patients, where a biological fixation by osseointegration guarantees a longer duration of the implants. 6 14 15 32 33 34 Therefore, the development of a cementless DM cup was motivated by the need to have a DM cup for the Zurich cementless prosthetic system to be used in dogs with a known increased risk of dislocation following a THA procedure. The adoption of carbon fibre ring (CFR)/polyether ether ketone (PEEK, Evonik, Germany) cup insert instead of highly crosslinked polyethylene since January 2016 in the Zurich system allowed the outer bearing of the DM cup to be made of PEEK, which is more resistant to wear when compared with polyethylene.…”

An assessment of the return to professional activity of patients aged ≤30 years after hip replacement surgery

“…Finally, 10 patients had never engaged in professional activity, and had been receiving disability benefit before the operation due to not being able to perform professional work. and the high expectations of the patient, alloplastic procedures in young patients present a unique challenge for orthopaedists dealing with hip replacement surgery [1,2].…”

Future of total hip arthroplasty with the Metha short stem in modern surgeries

“…Multidirectional and diverse studies on implants, carried out by a broad spectrum of specialists, have given rise to the development of special implants which can be used, efficiently meeting their role, even in the most advanced hip joint deformations. Both acetabular components, with their diameters below 44 mm, and anatomical stems, with diameters of less than 10 mm, as well as the use of computer navigation and, eventually, the modularity of implants, make it possible to carry out arthroplasty surgery in actual hip joint conditions which may be highly deviated from the normal human hip joint layout 1 – 3 .…”